AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00751582 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nutrition education
Description: Nutrition education for children for three months
Study NCT00751582 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control Group
Description: No Nutrition Education
Study NCT02450370 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low FODMAP diet
Description: Subjects in this group will follow a low FODMAP diet for up to 10 weeks. Foods that are high in oligosaccharides, disaccharides, monosaccharides and polyols will be avoided. They will receive 3 dietetic consultations at week 0,6 and 10. Dietary leaflets, including meal samples and Yes/No food lists will be provided.
Study NCT02450370 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Conventional IBS diet group
Description: Subjects in this group will follow a conventional diet for up to 10 weeks. They will receive 3 dietetic consultations at week 0,6 and 10. This diet will focus on small frequent meals, no skipping meals and dietary adjustments for bloatedness, diarrhea and constipation. Advice on intake of caffeine and alcohol will also be given. Dietary leaflets will be provided.
Study NCT03480048 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Breastfeeding and weight loss support
Description: The intervention is based on the Loving Support peer counseling breastfeeding model developed by the Special Supplemental Program for Women Infants and Children (WIC) with added components to promote postpartum weight loss.
Study NCT03432676 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epacadostat
Description: Given PO
Study NCT03432676 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Given IV
Study NCT00027534 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: TRICOM-CEA(6D)
Description: dendritic cells loaded with TRICOM-CEA(6D)
Study NCT04162418 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Temporary Spur Stent System
Description: Treatment of qualifying infrapopliteal lesions with Temporary Spur Stent System and a commercially available, limus-base drug-coated balloon
Study NCT03954366 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Rucaparib
Description: Rucaparib 600 mg BID commencing on Day 5 until Day 23.
Study NCT03954366 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Rosuvastatin
Description: Single dose of 20mg oral rosuvastatin on Day 1 and Day 19 only.
Study NCT03954366 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Oral Contraceptives
Description: Single dose of combined oral contraceptive (30 μg ethinylestradiol and 150 μg levonorgestrel) on Day 1 and Day 19 only.
Study NCT01094236 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: On the Playground behavior management program
Description: Treatment school playground supervisors were show the CD intervention. Control school playground supervisors were given a video on playground equipment safety. All school staff subjects were assessed before the intervention and 75 days following the supervisor intervention. Students were assessed before the intervention, and then 45 days and 75 days following the supervisor intervention. School Administrators were assessed before the intervention, and then 30 and 60 days after the supervisor intervention - school administrators at treatment schools had access to a treatment binder with CDs and worksheets, while the control school administrators did not.
Study NCT00904943 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topiramate Capsules, 25 mg
Description: 2 x 25 mg Capsules
Study NCT00904943 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Topamax® Capsules, 25 mg
Description: 2 x 25 mg Capsules
Study NCT02367898 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lumosity Cognitive Training
Description: adaptive online cognitive training
Study NCT02367898 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Crossword Puzzles
Description: timed online crossword puzzles
Study NCT04103138 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sedline EEG sensor placement
Description: Patients will have Sedline EEG sensor placed before or immediately after induction.
Study NCT04103138 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Sedline EEG sensor placement
Description: Patients will have Sedline EEG sensor placed before or immediately after induction.
Study NCT04103138 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sedline EEG monitoring
Description: Anaesthesia depth will be guided by EEG characteristics in addition to routine clinical parameters
Study NCT00061087 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methylphenidate
Description: Methylphenidate 80mg/day
Study NCT00061087 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupropion
Description: Bupropion 400mg/day
Study NCT00061087 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT04231578 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Couple HOPES Guided, Internet-Delivered, Self-Help Intervention
Description: Couple HOPES is a guided self-help intervention for individuals with PTSD and their partners based on Cognitive-Behavioral Conjoint Therapy for PTSD (Monson \& Fredman, 2012). This intervention consists of text and video-based content across seven intervention modules and phone and online-based coaching sessions with a paraprofessional. Participants are able to complete these modules in their own home or private location of their choosing. The primary outcomes are PTSD symptoms, relationship satisfaction, and the mental health and wellbeing of partners of those with PTSD.
Study NCT01317472 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dexlansoprazole
Description: 60 mg dexlansoprazole QAM (1 hour AC) for 2 months
Study NCT01317472 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 1 tablet of placebo QAM (1 hour AC) for 2 months
Study NCT05665231 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: A - Bone defect (clinical variables)
Description: At T0, the edentulous space to be rehabilitated will be characterized in terms of the morphometric level of the existing defect in the vestibular cortical, according to the classification by Caplanis N. in EDS-1 or EDS-2.
Study NCT05665231 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: A - Bone defect (clinical variables)
Description: At T0, the edentulous space to be rehabilitated will be characterized in terms of the morphometric level of the existing defect in the vestibular cortical, according to the classification by Caplanis N. in EDS-1 or EDS-2.
Study NCT05665231 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: B- Bacterial plaque index (O'Leary index)(clinical variables)
Description: At time T-1 and T4, the investigator will analyse the existing plaque on teeth adjacent to the surgical site using a dichotomous score (0 = no visible plaque at the soft tissue margin, 1 = visible plaque at the soft tissue margin). The result will be present in percentage (0% (better)-100%(worse)) and will describe the change between T-1 and T4, and compare the results between implants type.
Study NCT05665231 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: B- Bacterial plaque index (O'Leary index)(clinical variables)
Description: At time T-1 and T4, the investigator will analyse the existing plaque on teeth adjacent to the surgical site using a dichotomous score (0 = no visible plaque at the soft tissue margin, 1 = visible plaque at the soft tissue margin). The result will be present in percentage (0% (better)-100%(worse)) and will describe the change between T-1 and T4, and compare the results between implants type.
Study NCT05665231 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: C- Probing depth
Description: At Time T-1 and T4, the investigators will analyse the probing depth of the teeth adjacent to the site to be treated at 6 points: mesiobuccal, vestibular, distobuccal, mesiopalatal, palatine, distopalatal. The recordings will be carried out with a CP 15 UNC, Hu-Friedy® Chicago, IL, EUA manual probe.The result will be present in millimeters. The change between T-1 and T4 is also going to be analysed and compare implants results.
Study NCT05665231 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: C- Probing depth
Description: At Time T-1 and T4, the investigators will analyse the probing depth of the teeth adjacent to the site to be treated at 6 points: mesiobuccal, vestibular, distobuccal, mesiopalatal, palatine, distopalatal. The recordings will be carried out with a CP 15 UNC, Hu-Friedy® Chicago, IL, EUA manual probe.The result will be present in millimeters. The change between T-1 and T4 is also going to be analysed and compare implants results.
Study NCT05665231 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: D- Bleeding on probing
Description: At time T-1 and T4, the investigators will analyse the bleeding on probing of the teeth adjacent to the site to be treated at 6 points: mesiobuccal, vestibular, distobuccal, mesiopalatal, palatine, distopalatal. The recordings of bleeding on probing will be carried out with a CP 15 UNC, Hu-Friedy® Chicago, IL, EUA manual probe.The result will be present in percentage (0% (better)-100%(worse)) and will describe the change between T-1 and T4 and compare between implants type.
Study NCT05665231 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: D- Bleeding on probing
Description: At time T-1 and T4, the investigators will analyse the bleeding on probing of the teeth adjacent to the site to be treated at 6 points: mesiobuccal, vestibular, distobuccal, mesiopalatal, palatine, distopalatal. The recordings of bleeding on probing will be carried out with a CP 15 UNC, Hu-Friedy® Chicago, IL, EUA manual probe.The result will be present in percentage (0% (better)-100%(worse)) and will describe the change between T-1 and T4 and compare between implants type.
Study NCT05665231 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: E- Gingival phenotype
Description: At time T-1, the identification of the gingival phenotype is performed by clinical inspection with a periodontal probe. The gingival phenotype will be classified as thin, moderate or thick. The investigators will compare implant results.
Study NCT05665231 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: E- Gingival phenotype
Description: At time T-1, the identification of the gingival phenotype is performed by clinical inspection with a periodontal probe. The gingival phenotype will be classified as thin, moderate or thick. The investigators will compare implant results.
Study NCT05665231 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: F- Implant insertion torque (Clinical variables)
Description: Recording of implant insertion torque, in Ncm during placement in T1, and compare implants results.
Study NCT05665231 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: F- Implant insertion torque (Clinical variables)
Description: Recording of implant insertion torque, in Ncm during placement in T1, and compare implants results.
Study NCT05665231 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: G- Implant stabilization quotient (ISQ) (clinical variables)
Description: Determination of the implant stability coefficient at the time of implant placement (T1) and in the 2nd surgical phase (T3) using the Osstell® device (minimum 1; maximum 100; high stability when ≥70) and analysis of the change between T1 and T3 and different implants results.
Study NCT05665231 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: G- Implant stabilization quotient (ISQ) (clinical variables)
Description: Determination of the implant stability coefficient at the time of implant placement (T1) and in the 2nd surgical phase (T3) using the Osstell® device (minimum 1; maximum 100; high stability when ≥70) and analysis of the change between T1 and T3 and different implants results.
Study NCT05665231 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Morphometric results (Direct measurements - millimeter)
Description: Compare Direct measurements (millimeters) at the different times intervention with periodontal probe or gauge and analyse the change between times and compare implant results.~In T-1, T2 and T3c and T4 the investigators will evaluate interdental distance; BPD, cortical bone, papilla and volume, corresponding of measurements: a,b,c and r.~In T0, the investigators will evaluate interdental distance; BPD, cortical, bone and global volume corresponding to measurements: a, b, c, d, e, q, r, s, t, and u).~In T1 e T3, the investigators will evaluate interdental distance; BPD, cortical, bone and global volume, implant parameter corresponding to measurements: a, b, d, e, f, g, h, I, j, k, l, m, n, p, q, r and ISQ value.
Study NCT05665231 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Morphometric results (Direct measurements - millimeter)
Description: Compare Direct measurements (millimeters) at the different times intervention with periodontal probe or gauge and analyse the change between times and compare implant results.~In T-1, T2 and T3c and T4 the investigators will evaluate interdental distance; BPD, cortical bone, papilla and volume, corresponding of measurements: a,b,c and r.~In T0, the investigators will evaluate interdental distance; BPD, cortical, bone and global volume corresponding to measurements: a, b, c, d, e, q, r, s, t, and u).~In T1 e T3, the investigators will evaluate interdental distance; BPD, cortical, bone and global volume, implant parameter corresponding to measurements: a, b, d, e, f, g, h, I, j, k, l, m, n, p, q, r and ISQ value.
Study NCT05665231 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Morphometric results (plaster models measurements - millimeter)
Description: Preparation of plaster models at times T-1 and T4 and the following measurements (millimeter) will be evaluated with the use of periodontal probe or gauge and will analyse the change between T-1 and T4 and compare implants results:~1. interdental distance~2. bucco-palatal distance (BPD)~3. presence of papilla~r. global volume.
Study NCT05665231 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Morphometric results (plaster models measurements - millimeter)
Description: Preparation of plaster models at times T-1 and T4 and the following measurements (millimeter) will be evaluated with the use of periodontal probe or gauge and will analyse the change between T-1 and T4 and compare implants results:~1. interdental distance~2. bucco-palatal distance (BPD)~3. presence of papilla~r. global volume.
Study NCT05665231 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Imaging Results (X-ray) (millimeter)
Description: The investigator will measure (millimeters, using the imaging software virtual ruler) the results of digital X-ray at times T-1, T1,T4 and analyse the variation and compare implants results. The measurements are:~a. interdental distance; i. implant - cemento-enamel junction (CEJ) of adject teeth distance; l. distance from the implant position depth to the buccal bone crest; n. implant diameter; o. implant length.
Study NCT05665231 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Imaging Results (X-ray) (millimeter)
Description: The investigator will measure (millimeters, using the imaging software virtual ruler) the results of digital X-ray at times T-1, T1,T4 and analyse the variation and compare implants results. The measurements are:~a. interdental distance; i. implant - cemento-enamel junction (CEJ) of adject teeth distance; l. distance from the implant position depth to the buccal bone crest; n. implant diameter; o. implant length.
Study NCT05665231 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Imaging Results (CBCT)(millimeter)
Description: The investigator will measure (millimeters, using the imaging software virtual ruler) the results of CBCT at times T-1 and T4, analyse the variation and compare implants results. The measurements are:~1. interdental distance;~2. bucco-palatal distance (BPD);~d. buccal cortical distance; e. palatal cortical distance; f. mesial cortical distance; g. distal cortical distance; h. jumping distance; j. buccal cortical wall-implant distance; k. jumping distance space depth; l. distance from the implant position depth to the buccal bone crest; m. distance from the buccal cortex to the center of the implant; n. implant diameter; o. Implant length; q. global bone volume; r. global volume; s. alveolus buccal-palatal distance; t. alveolus mesial-distal distance; u. alveolus depth.
Study NCT05665231 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Imaging Results (CBCT)(millimeter)
Description: The investigator will measure (millimeters, using the imaging software virtual ruler) the results of CBCT at times T-1 and T4, analyse the variation and compare implants results. The measurements are:~1. interdental distance;~2. bucco-palatal distance (BPD);~d. buccal cortical distance; e. palatal cortical distance; f. mesial cortical distance; g. distal cortical distance; h. jumping distance; j. buccal cortical wall-implant distance; k. jumping distance space depth; l. distance from the implant position depth to the buccal bone crest; m. distance from the buccal cortex to the center of the implant; n. implant diameter; o. Implant length; q. global bone volume; r. global volume; s. alveolus buccal-palatal distance; t. alveolus mesial-distal distance; u. alveolus depth.
Study NCT05665231 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Photographic results PES/WES index
Description: The investigator will analyse the intraoral photographs to describe the Pes/Wes index, in time T-1 (initial) and T4 (final), and compare the PES/WES results between implants.The score will range on 0-10, the best score is ≥8.
Study NCT05665231 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Photographic results PES/WES index
Description: The investigator will analyse the intraoral photographs to describe the Pes/Wes index, in time T-1 (initial) and T4 (final), and compare the PES/WES results between implants.The score will range on 0-10, the best score is ≥8.
Study NCT04445285 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pulmozyme/ Recombinant human deoxyribonuclease (rh-DNase)
Description: 2.5mg Pulmozyme/ Recombinant human deoxyribonuclease (rh-DNase) aerosolized treatment once every 24 hours for five (5) consecutive days; a total of five (5) doses
Study NCT04445285 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 0.9%sodium chloride
Description: Placebo of 0.9% sodium chloride every 24 hours for five (5) consecutive days; a total of 5 doses
Study NCT04699617 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dolphin 2.0
Description: The Dolphin 2.0 is a platform that runs an immersive virtual reality software, based on an oceanic environment, where players control simulated creatures.
Study NCT04699617 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Dolphin 2.0
Description: The Dolphin 2.0 is a platform that runs an immersive virtual reality software, based on an oceanic environment, where players control simulated creatures.
Study NCT03264677 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Group 1
Description: NTG Hydro Boost Gelee Milk Cleanser + NTG Hydro Boost Kiwi Water Gel
Study NCT03264677 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Group 2
Description: NTG Hydro Boost Gelee Milk Cleanser + NTG Hydro Boost Water Gel
Study NCT03264677 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Group 3
Description: NTG Hydro Boost Gelee Milk Cleanser + NTG Hydro Boost Extra Dry Emulsion
Study NCT03692598 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MIA, Minimally Invasive Annuloplasty Device - Surgical
Description: Eligible patients will receive implantation of MIA implants deployed using the MIA, Minimally Invasive Annuloplasty Device from an open surgical approach
Study NCT03692598 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MIA, Minimally Invasive Annuloplasty Device - Percutaneous
Description: Eligible patients will receive implantation of MIA implants deployed using the MIA, Minimally Invasive Annuloplasty Device from a percutaneous approach
Study NCT03363841 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SCY-078
Description: Oral SCY-078
Study NCT01951443 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ginseng
Description: 400mg of encapsulated Rg3-KRG
Study NCT01951443 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Wheat Bran
Description: 400mg of encapsulated wheat bran
Study NCT04538521 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Niacin
Description: The dose for a slow-released form of niacin will be 500-1000 mg/day. The daily niacin dose, 250 mg/day, is gradually escalated by 250 mg/month so that the full dose is reached after 2 months. The intervention time with the full niacin dose is 8 months and subsequently total intervention time 10 months.
Study NCT02559453 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Debridement
Description: Removing dead tissue from infected wounds.
Study NCT00072462 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: tamoxifen citrate
Description: Tamoxifen 20mg + Anastrozole placebo
Study NCT00072462 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Anastrozole
Description: Anastrozole 1mg + Tamoxifen placebo
Study NCT03913936 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: YES portal
Description: The YES portal is designed to collect and assess participants' toxicities and symptoms, as well as informational needs in between visits with their clinician
Study NCT03036098 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Specified Dose on Specified Days
Study NCT03036098 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Description: Specified Dose on Specified Days